theophylline has been researched along with Infant, Newborn, Diseases in 36 studies
Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This, and the known high incidence of apneas in infants who subsequently are victims of sudden infant death syndrome, has led to aggressive attempts at early identification of newborns with abnormal cardio-respiratory patterns." | 7.67 | Apnea in newborn infants: approach to management. ( Banagale, RC; Howatt, WF; Roloff, DW, 1984) |
| " The periodic breathing and apnea seemed to be caused by a decreased oxygen tension which can induce an instability of the central respiratory control mechanisms." | 7.66 | Ventilatory studies in two older infants with prolonged apnea. ( Broberger, U; Lagercrantz, H; Milerad, J; von Euler, C, 1980) |
| " Treatment of neonatal apnea with theophylline as documented by a normal follow-up pneumocardiogram should be considered successful only when the levels of both theophylline and caffeine have been documented subtherapeutic at time of re-test." | 7.66 | Effect of serum caffeine level on pneumocardiogram of premature infants treated for apnea with theophylline. ( Banagale, RC, 1982) |
| "Theophylline and caffeine are both effective stimulants of the central nervous system for the therapy of neonatal apnea." | 7.66 | Pharmacologic considerations in the therapy of neonatal apnea. ( Aranda, JV; Grondin, D; Sasyniuk, BI, 1981) |
| "Twenty-two full-term infants, aged 0 to 6 weeks, with a history of unexplained apnea and respiratory abnormalities on pneumogram recordings, were treated with theophylline (average dose 7." | 7.66 | Treatment of apnea and excessive periodic breathing in the full-term infant. ( Kelly, DH; Shannon, DC, 1981) |
| "9 micrograms/ml) were observed in seven premature infants with severe idiopathic apnea." | 7.66 | Low-dose theophylline therapy in idiopathic apnea of prematurity. ( Auld, PA; Krauss, AN; Milsap, RL; Myers, TF; Reidenberg, MM, 1980) |
| " This, and the known high incidence of apneas in infants who subsequently are victims of sudden infant death syndrome, has led to aggressive attempts at early identification of newborns with abnormal cardio-respiratory patterns." | 3.67 | Apnea in newborn infants: approach to management. ( Banagale, RC; Howatt, WF; Roloff, DW, 1984) |
| " Furthermore, our data imply that an overactivity of central adenosine mechanisms may have a pathophysiological significance for the irregular breathing or apnea of prematurity sometimes seen in the human neonate." | 3.67 | Characterization of adenosine-induced respiratory depression in the preterm rabbit. ( Bergman, B; Hedner, J; Hedner, T; Jonason, J; Mueller, RA, 1985) |
| "5 months but who was equipped with an apnea monitor at home on psychological indications." | 3.66 | A case of near-miss SIDS developing an abnormal respiratory reaction to hypoxia. ( Bjure, J; Kjellmer, I; Wennergren, G, 1983) |
| " The periodic breathing and apnea seemed to be caused by a decreased oxygen tension which can induce an instability of the central respiratory control mechanisms." | 3.66 | Ventilatory studies in two older infants with prolonged apnea. ( Broberger, U; Lagercrantz, H; Milerad, J; von Euler, C, 1980) |
| " Treatment of neonatal apnea with theophylline as documented by a normal follow-up pneumocardiogram should be considered successful only when the levels of both theophylline and caffeine have been documented subtherapeutic at time of re-test." | 3.66 | Effect of serum caffeine level on pneumocardiogram of premature infants treated for apnea with theophylline. ( Banagale, RC, 1982) |
| "Theophylline and caffeine are both effective stimulants of the central nervous system for the therapy of neonatal apnea." | 3.66 | Pharmacologic considerations in the therapy of neonatal apnea. ( Aranda, JV; Grondin, D; Sasyniuk, BI, 1981) |
| "Twenty-two full-term infants, aged 0 to 6 weeks, with a history of unexplained apnea and respiratory abnormalities on pneumogram recordings, were treated with theophylline (average dose 7." | 3.66 | Treatment of apnea and excessive periodic breathing in the full-term infant. ( Kelly, DH; Shannon, DC, 1981) |
| "Theophylline is a safe, effective drug for the treatment of apnea of prematurity." | 3.66 | Pharmacokinetics of theophylline in neonates. ( Rigatto, H; Simons, FE; Simons, KJ, 1981) |
| " This view assumes that pharmacologic manipulation of apnea of prematurity is in itself a desirable goal and clearly superior to treatment of apneic episodes when they occur." | 3.66 | Adverse effects of caffeine and theophylline in the newborn infant. ( Aranda, JV; Clozel, M; Howell, J, 1981) |
| "Theophylline (T) tissue distribution was studied in 11 premature newborns treated with T for prematurity apnea, who had died from severe pathology." | 3.66 | Theophylline distribution in the premature neonate. ( Assael, BM; Bonati, M; Latini, R; Marra, G; Parini, R, 1981) |
| "9 micrograms/ml) were observed in seven premature infants with severe idiopathic apnea." | 3.66 | Low-dose theophylline therapy in idiopathic apnea of prematurity. ( Auld, PA; Krauss, AN; Milsap, RL; Myers, TF; Reidenberg, MM, 1980) |
| "One of a pair of preterm twins treated with theophylline (2 mg/kg per day) for apnoea developed episodes of hyperglycaemia in glycosuria." | 3.66 | Theophylline toxicity in a neonate. ( Drayton, MR; Gamsu, HR; Larcher, VF; Sanderson, MC; Sandhu, B, 1978) |
| "Successful pregnancy is described in a patient with beta-thalassaemia major, transfusion-dependent from four months of age and treated with desferrioxamine from 13 years of age." | 1.27 | Successful pregnancy in beta-thalassaemia major. ( Martin, K, 1983) |
| "Theophylline has recently shown to affect lymphocyte reactivity." | 1.26 | Effects of theophylline on the neonatal immune response. ( Baley, JE; Miller, K; Pittard, WB; Ruuskanen, O, 1982) |
| "All had central sleep apnea, three had hypoventilation, and none had obstructive apnea observed on polygraphic recordings." | 1.26 | Episodic complete airway obstruction in infants. ( Kelly, DH; Shannon, DC, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banagale, RC | 2 |
| Roloff, DW | 1 |
| Howatt, WF | 1 |
| Caputo, RV | 1 |
| Rajchgot, P | 1 |
| MacLeod, S | 1 |
| Martin, K | 1 |
| Tudehope, DI | 1 |
| Rogers, Y | 1 |
| Aranda, JV | 3 |
| Scalais, E | 1 |
| Papageorgiou, A | 1 |
| Beharry, K | 1 |
| Wennergren, G | 1 |
| Bjure, J | 1 |
| Kjellmer, I | 1 |
| Lagercrantz, H | 1 |
| Broberger, U | 1 |
| Milerad, J | 1 |
| von Euler, C | 1 |
| Nelson, RM | 1 |
| Resnick, MB | 1 |
| Zenk, KE | 1 |
| Horowitz, DA | 1 |
| Jablonski, WJ | 1 |
| Mehta, KA | 1 |
| Baley, JE | 1 |
| Ruuskanen, O | 1 |
| Miller, K | 1 |
| Pittard, WB | 1 |
| Kelly, DH | 2 |
| Shannon, DC | 2 |
| Grondin, D | 1 |
| Sasyniuk, BI | 1 |
| Milsap, RL | 2 |
| Krauss, AN | 2 |
| Auld, PA | 2 |
| Somani, SM | 1 |
| Khanna, NN | 1 |
| Simons, FE | 1 |
| Rigatto, H | 1 |
| Simons, KJ | 1 |
| Takieddine, FN | 1 |
| Tserng, KY | 1 |
| King, KC | 1 |
| Kalhan, SC | 1 |
| Howell, J | 1 |
| Clozel, M | 1 |
| Bonati, M | 1 |
| Latini, R | 1 |
| Marra, G | 1 |
| Assael, BM | 1 |
| Parini, R | 1 |
| Myers, TF | 1 |
| Reidenberg, MM | 1 |
| Floberg, S | 1 |
| Lindström, B | 1 |
| Lönnerholm, G | 1 |
| Williams, AJ | 1 |
| Peabody, JL | 1 |
| Buchanan, N | 1 |
| Arwood, LL | 1 |
| Dasta, JF | 1 |
| Friedman, C | 1 |
| Rooklin, AR | 1 |
| Moomjian, AS | 1 |
| Shutack, JG | 1 |
| Schwartz, JG | 1 |
| Fox, WW | 1 |
| Melchior, JB | 1 |
| Hommes, PM | 1 |
| Jarrett, TE | 1 |
| McClain, W | 1 |
| Wasserlauf, H | 1 |
| Olive, G | 1 |
| Larcher, VF | 1 |
| Gamsu, HR | 1 |
| Sanderson, MC | 1 |
| Drayton, MR | 1 |
| Sandhu, B | 1 |
| Sodoyez-Goffaux, F | 1 |
| Sodoyez, JC | 1 |
| Hedner, T | 1 |
| Hedner, J | 1 |
| Bergman, B | 1 |
| Mueller, RA | 1 |
| Jonason, J | 1 |
| Beutnagel, H | 1 |
| Schöber, JG | 1 |
| Schmidramsl, H | 1 |
| Riegel, K | 1 |
| Kaiser, D | 1 |
| Nadjafian, C | 1 |
| Werner, E | 1 |
5 reviews available for theophylline and Infant, Newborn, Diseases
| Article | Year |
|---|---|
Recent advances in pediatric dermatology.
Topics: Amniocentesis; Arthritis, Infectious; Candidiasis, Cutaneous; Child; Child, Preschool; Cicatrix; Dru | 1983 |
Perinatal pharmacology.
Topics: Biotransformation; Female; Fetus; Glucocorticoids; Humans; Infant, Newborn; Infant, Newborn, Disease | 1983 |
An overview of perinatal clinical pharmacology.
Topics: Abnormalities, Drug-Induced; Analgesics; Bupivacaine; Carbamazepine; Chloramphenicol; Diazepam; Digo | 1981 |
Transcutaneous oxygen measurement to evaluate drug effects.
Topics: Anesthesia, Obstetrical; Apnea; Electrodes; Female; Fetal Monitoring; Humans; Infant, Newborn; Infan | 1979 |
Clinical pharmacology of theophylline.
Topics: Administration, Oral; Adolescent; Adult; Aging; Apnea; Arterioles; Biological Availability; Bronchia | 1979 |
31 other studies available for theophylline and Infant, Newborn, Diseases
| Article | Year |
|---|---|
Apnea in newborn infants: approach to management.
Topics: Apnea; Electrocardiography; Home Nursing; Humans; Infant, Newborn; Infant, Newborn, Diseases; Monito | 1984 |
Successful pregnancy in beta-thalassaemia major.
Topics: Adult; Blood Transfusion; Deferoxamine; Female; Glucose; Humans; Hypoglycemia; Infant, Newborn; Infa | 1983 |
Clinical spectrum of neonatal apnoea in very low birthweight infants.
Topics: Apnea; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Newborn, Diseases; Male; R | 1984 |
Ontogeny of human caffeine and theophylline metabolism.
Topics: Adult; Aged; Apnea; Caffeine; Child; Child, Preschool; Half-Life; Humans; Infant; Infant, Newborn; I | 1984 |
A case of near-miss SIDS developing an abnormal respiratory reaction to hypoxia.
Topics: Apnea; Humans; Hypoxia; Infant, Newborn; Infant, Newborn, Diseases; Male; Monitoring, Physiologic; P | 1983 |
Ventilatory studies in two older infants with prolonged apnea.
Topics: Apnea; Carbon Dioxide; Female; Heart Rate; Humans; Infant; Infant, Newborn; Infant, Newborn, Disease | 1980 |
Long-term outcome of premature infants treated with theophylline.
Topics: Apnea; Child Development; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Newborn, Disea | 1981 |
Apnea associated with theophylline withdrawal in a term neonate.
Topics: Apnea; Caffeine; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Maternal-Fetal Exchange | 1982 |
Effects of theophylline on the neonatal immune response.
Topics: Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Infant, Newborn; Infa | 1982 |
Effect of serum caffeine level on pneumocardiogram of premature infants treated for apnea with theophylline.
Topics: Apnea; Caffeine; Electrocardiography; False Negative Reactions; Humans; Infant, Newborn; Infant, New | 1982 |
Episodic complete airway obstruction in infants.
Topics: Airway Obstruction; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Infant, Newb | 1981 |
Pharmacologic considerations in the therapy of neonatal apnea.
Topics: Apnea; Caffeine; Humans; Infant, Newborn; Infant, Newborn, Diseases; Monitoring, Physiologic; Theoph | 1981 |
Treatment of apnea and excessive periodic breathing in the full-term infant.
Topics: Apnea; Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Male; Sleep Apnea Syndrom | 1981 |
Efficacy of low-dose theophylline.
Topics: Apnea; Bradycardia; Heart Rate; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Prematur | 1981 |
Methylxanthines in serum, saliva, and spinal fluid of premature infants.
Topics: Apnea; Caffeine; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Kinetics; Sa | 1981 |
Pharmacokinetics of theophylline in neonates.
Topics: Apnea; Half-Life; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Kinetics; T | 1981 |
Postnatal development of theophylline metabolism in preterm infants.
Topics: Adult; Aging; Child; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; | 1981 |
Adverse effects of caffeine and theophylline in the newborn infant.
Topics: Apnea; Asphyxia Neonatorum; Caffeine; Cardiovascular System; Central Nervous System; Digestive Syste | 1981 |
Theophylline distribution in the premature neonate.
Topics: Aging; Animals; Animals, Newborn; Apnea; Blood-Brain Barrier; Female; Gestational Age; Guinea Pigs; | 1981 |
Low-dose theophylline therapy in idiopathic apnea of prematurity.
Topics: Apnea; Bradycardia; Carbon Dioxide; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infa | 1980 |
Simultaneous determination of theophylline and caffeine after extractive alkylation in small volumes of plasma by gas chromatography--mass spectrometry.
Topics: Alkylation; Apnea; Caffeine; Gas Chromatography-Mass Spectrometry; Humans; Infant, Newborn; Infant, | 1980 |
Xanthines and necrotising entercolitis.
Topics: Diseases in Twins; Enterocolitis, Pseudomembranous; Humans; Infant, Newborn; Infant, Newborn, Diseas | 1980 |
Placental transfer of theophylline: two case reports.
Topics: Administration, Oral; Aminophylline; Asthma; Female; Fetus; Humans; Infant, Newborn; Infant, Newborn | 1979 |
Theophylline therapy in bronchopulmonary dysplasia.
Topics: Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Lung Diseases; Respiratory Distress Synd | 1979 |
A micromethod for the determination of serum theophylline.
Topics: Apnea; Humans; Infant, Newborn; Infant, Newborn, Diseases; Methods; Theophylline | 1978 |
[Pharmacological basis of therapeutic monitoring during the perinatal period (proceedings)].
Topics: Age Factors; Anti-Bacterial Agents; Anticonvulsants; Birth Weight; Cardiac Glycosides; Dose-Response | 1978 |
Theophylline toxicity in a neonate.
Topics: Apnea; Diseases in Twins; Glycosuria; Humans; Hyperglycemia; Infant, Newborn; Infant, Newborn, Disea | 1978 |
Transient diabetes mellitus in a neonate. Evaluation of insulin, glucagon, and growth hormone secretion and management with a continuous low-dose insulin infusion.
Topics: Adolescent; Antigens; Blood Glucose; Diabetes Mellitus, Type 1; Female; Glucagon; Glucose Tolerance | 1977 |
Characterization of adenosine-induced respiratory depression in the preterm rabbit.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Animals, Newborn; Apnea; Humans; Infant, Newb | 1985 |
[Effect of perphyllon A 13 on the cardiorespiratory function in healthy newborn infants and on those with adaptation disorders].
Topics: Adaptation, Physiological; Arteries; Atropine; Blood Pressure; Cardiovascular System; Heart Rate; Hu | 1972 |
[Effect of Perphyllon A on gas exchange, energy balance and peripheral oxygen supply of the newborn].
Topics: Acidosis; Humans; Hypercapnia; Infant, Newborn; Infant, Newborn, Diseases; Lactates; Oxygen Consumpt | 1969 |